Pemphigus vulgaris: update on etiopathogenesis, oral manifestations, and management

C Scully, SJ Challacombe - Critical Reviews in Oral Biology …, 2002 - journals.sagepub.com
Pemphigus is a group of potentially life-threatening diseases characterized by cutaneous
and mucosal blistering. There is a fairly strong genetic background to pemphigus with …

Interleukin-10: biology, role in inflammation and autoimmunity

I Lalani, K Bhol, AR Ahmed - Annals of Allergy, Asthma & Immunology, 1997 - Elsevier
LEARNING OBJECTIVES: Reading this article will increase the readers' knowledge of the
biology of interleukin-10 (IL-10), an important cytokine. The survival of an organism and its …

Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure

L Gullestad, H Aass, JG Fjeld, L Wikeby… - Circulation, 2001 - Am Heart Assoc
Background—Congestive heart failure (CHF) is characterized by enhanced immune
activation, and immune-mediated mechanisms may play a pathogenic role in this disorder …

Inflammatory and anti‐inflammatory cytokines in chronic heart failure: potential therapeutic implications

P Aukrust, L Gullestad, T Ueland, JK Damås… - Annals of …, 2005 - Taylor & Francis
Persistent inflammation, involving increased levels of inflammatory cytokines, seems to play
a pathogenic role in chronic heart failure (HF) by influencing heart contractility, inducing …

Consensus statement on the use of intravenous immunoglobulin therapy in the treatment of autoimmune mucocutaneous blistering diseases

AR Ahmed, MV Dahl - Archives of dermatology, 2003 - jamanetwork.com
Objectives The purpose of the meeting of the Consensus Development Group was to
critically evaluate the current published data on the use of intravenous immunoglobulin …

Brief report: Dysregulated immune system in children with autism: Beneficial effects of intravenous immune globulin on autistic characteristics.

S Gupta, S Aggarwal - Journal of Autism & Developmental …, 1996 - search.ebscohost.com
Discusses the immune response to intravenous immune globulin (IVIG) in autism.
Examination of T cells, B cells, NK cells, and serum IgM, IgA, IgE, IgG1, IgG2, IgG3 and IgG4 …

Number II
Pemphigus vulgaris

M Black, MD Mignogna, C Scully - Oral diseases, 2005 - Wiley Online Library
Pemphigus is a group of potentially life‐threatening autoimmune diseases characterized by
cutaneous and/or mucosal blistering. Pemphigus vulgaris (PV), the most common variant, is …

Review of trials in chronic heart failure showing broad-spectrum anti-inflammatory approaches

L Gullestad, P Aukrust - The American journal of cardiology, 2005 - Elsevier
Accumulating evidence indicates that inflammatory mediators are important in the
pathogenesis of chronic heart failure (CHF), contributing to cardiac remodeling and …

Intravenous immunoglobulin therapy for patients with idiopathic cardiomyopathy and endomyocardial biopsy-proven high PVB19 viral load

R Dennert, S Velthuis, S Schalla, L Eurlings… - Antiviral …, 2010 - journals.sagepub.com
Background Parvovirus B19 (PVB19) persistence in the heart has been associated with
progressive cardiac dysfunction and evolution to dilated cardiomyopathy. In the present …

Intravenous immunoglobulin therapy in the treatment of patients with pemphigus vulgaris unresponsive to conventional immunosuppressive treatment

AR Ahmed - Journal of the American Academy of Dermatology, 2001 - Elsevier
Background: Severe pemphigus vulgaris (PV) is conventionally treated with high-dose oral
prednisone, usually in combination with an immunosuppressive agent (ISA). Some patients …